Publications
5808 Results
- Journal / Conference
- Int J Radiat Oncol Biol Phys 54(2):2-3(#4)
- Year
- 2002
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-9201 (RTOG-91-11)
Larynx preservation and tumor control in stage III and IV laryngeal cancer: a three-arm randomized Intergroup trial; RTOG 91-11
- Journal / Conference
- Journal of Clinical Oncology 20(16):3369-3375
- Year
- 2002
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9452 (INT-0159) (CALGB 9480)
Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of Intergroup 0159, Cancer and Leukemia Group B 9480
- Journal / Conference
- ASCO/Molecular Therapeutics Symposium, San Diego CA :#52
- Year
- 2002
A phase I study of a HER-2/neu intracellular protein (HER2 ICD) vaccine in patients with HER2 overexpressing breast or ovarian cancer
- Journal / Conference
- Journal of the American Medical Association 287(3):321-328
- Year
- 2002
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9411
Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer
- Journal / Conference
- Oncology 16(3):291-296
- Year
- 2002
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
The Das/Kaplan article reviewed: The role of PC-SPES, selenium, and Vitamin E in prostate cancer
- Journal / Conference
- Classic Papers and Current Comments 7(1):174-181
- Year
- 2002
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12)
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
- Journal / Conference
- Classic Papers and Current Comments 7(1):41-52
- Year
- 2002
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8412
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer
- Journal / Conference
- Classic Papers and Current Comments 7(1):92-99
- Year
- 2002
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-9227 (GOG-114)
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and Intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: and Intergroup study of the GOG, SWOG, and ECOG
- Journal / Conference
- In: Lambers SWJ and Dogliotti L, eds. Advances in Oncology: the expanding role of octreotide I. Bioscientifica Press, Bristol, UK, pp. 227-234
- Year
- 2002
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- E1295
Randomized trial of standard dose loperamide, low-dose octreotide acetate, or high dose octreotide acetate for chemotherapy induced diarrhea (E1295): an Intergroup study of the Eastern Cooperative Oncology Group
- Journal / Conference
- American Journal of Clinical Oncology 24(1):10-18
- Year
- 2001
- Research Committee(s)
- Breast